Smisson-Cartledge Biomedical, LLC — Form D

Smisson-Cartledge Biomedical, LLC of MACON, GA, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-27. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Richard G. Cartledge, M.D.DirectorHollywood, FL
Calder B. Clay IIIDirectorMacon, GA
Christopher T. CollinsDirectorMacon, GA
David C. FieldDirectorMacon, GA
Thomas W. Glasgow, Jr.DirectorAsheville, NC
Hugh F. Smisson III, M.D.DirectorMacon, GA
Steve T. ZenezakDirectorBrecksville, OH
Richard G. Cartledge, M.D.Executive OfficerHollywood, FL
Calder B. Clay IIIExecutive OfficerMacon, GA
David C. FieldExecutive OfficerMacon, GA
Hugh F. Smisson III, M.D.Executive OfficerMacon, GA
Richard G. Cartledge, M.D.PromoterHollywood, FL
Calder B. Clay IIIPromoterMacon, GA
Christopher T. CollinsPromoterMacon, GA
David C. FieldPromoterMacon, GA
Hugh F. Smisson III, M.D.PromoterMacon, GA
Calder B Clay IIIDirectorMacon, GA
Calder B Clay IIIExecutive OfficerMacon, GA
Calder B Clay IIIPromoterMacon, GA
David C FieldDirectorMacon, GA
David C FieldExecutive OfficerMacon, GA
David C FieldPromoterMacon, GA
Richard G Cartledge, M.D.DirectorHollywood, FL
Richard G Cartledge, M.D.Executive OfficerHollywood, FL
Richard G Cartledge, M.D.PromoterHollywood, FL

Other filings by this issuer (3)

FiledFormOfferingSold
2012-05-21D$1.0M$1.0M
2011-11-16D$700K$317K
2010-12-16D$1.0M$116K

More